Bausch Health Companies Inc Stock Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.39B 12.83B | Sales 2025 * | 9.45B 12.93B | Capitalization | 3.13B 4.28B |
---|---|---|---|---|---|
Net income 2024 * | 336M 459M | Net income 2025 * | 381M 521M | EV / Sales 2024 * | 2.45 x |
Net Debt 2024 * | 19.91B 27.22B | Net Debt 2025 * | 18.33B 25.06B | EV / Sales 2025 * | 2.27 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
8.28
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.66% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+27.92% | 672B | |
+27.10% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.42% | 217B | |
+6.00% | 199B | |
-8.79% | 204B | |
-8.58% | 149B |